Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions

NCT04987606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-04-18

No results posted yet for this study

Summary

This study aims to understand why some people who have had COVID-19 develop scarring of the lungs and why some people recover more quickly than others.

Conditions

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2023-04-01
Completion
2024-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04987606 on ClinicalTrials.gov